On November 12, 2013, GeneLink Inc. appointed Michael G. Smith as Chief Operating Officer and Interim Chief Financial Officer of the Company effective November 12, 2013. Michael G. Smith, age 47, has been employed by GeneLink Inc. as Sr. Vice President of Operations since September 1, 2012. Prior to that, Mr. Smith spent more than 25 years working for large public companies, working with high growth companies, and building startups.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | +900.00% |
2015 | GeneLink Inc. Emerged from Bankruptcy | CI |
2015 | Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+900.00% | 2.65K | |
-24.25% | 7.76B | |
+67.56% | 4.35B | |
+2.59% | 2.67B | |
-2.45% | 2.64B | |
-47.56% | 2.1B | |
-17.86% | 1.73B | |
-19.62% | 1.52B | |
+12.59% | 1.18B | |
-45.36% | 1.11B |
- Stock Market
- Equities
- GNLKQ Stock
- News GeneLink, Inc.
- GeneLink, Inc. Appoints Michael G. Smith as Chief Operating Officer and Interim Chief Financial Officer